Search Results - "Blondet, N"
-
1
Serum bile acids are associated with native liver survival in patients with Alagille syndrome: results from the GALA study group
Published in JOURNAL OF HEPATOLOGY (01-06-2023)Get full text
Journal Article Conference Proceeding -
2
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study
Published in Hepatology communications (01-03-2023)“…Approximately 3.5 million children and adolescents worldwide are chronically infected with HCV. This study uses pharmacokinetic modeling to identify pediatric…”
Get full text
Journal Article -
3
OC7 Maralixibat-treated patients with Alagille syndrome demonstrate event-free survival in a natural history comparison with patients with from the GALA database: application of real-world evidence analytics
Published in Frontline gastroenterology (01-07-2023)“…Real-world evidence (RWE) analytics continue to advance natural history comparisons in rare diseases. The Global Alagille Alliance (GALA) is the largest global…”
Get full text
Journal Article -
4
-
5
DEVELOPMENT OF A NOVEL MODEL TO SUPPORT ELBASVIR/GRAZOPREVIR USE IN CHILDREN WITH CHRONIC HEPATITIS C VIRUS (HCV) GENOTYPES (GT) 1 OR 4 INFECTION
Published in HEPATOLOGY (2019)Get full text
Conference Proceeding -
6